Equasens

Equasens EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Equasens (EQS.PA) as of Oct 19, 2026 is 10.95. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 15.52 — a change of -29.45% (lower).

EV/FCF

10.95

YoY

-29.45%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Equasens is 2025 10.95 . EV/FCF (Enterprise Value to Free Cash Flow) of Equasens was 2024 15.52 . It decreases by -29.45% lower compared to the previous year.

The Equasens EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
30.05 EUR
Jan 1, 2019
23.14 EUR
Jan 1, 2020
20.15 EUR
Jan 1, 2021
15.32 EUR
Jan 1, 2022
11.71 EUR
Jan 1, 2023
13.05 EUR
Jan 1, 2024
15.52 EUR
Jan 1, 2025
10.95 EUR
The Equasens EV/FCF history
YEAREV/FCFYoY
10.95-29.45%
15.52+18.89%
13.05+11.47%
11.71-23.56%
15.32-23.96%
20.15-12.93%
23.14-22.99%
30.05+14.74%
26.19-13.88%
30.41+13.31%
26.84-15.13%
31.62—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Equasens Stock analysis

What does Equasens do? Pharmagest Interactive SA is a leading provider of digital solutions for pharmacies and healthcare providers. The company was founded in France in 1986 and is headquartered in Villers-lès-Nancy. The company offers a wide range of software solutions for healthcare providers and pharmacies. Its main business areas include pharmacy management systems, healthcare management solutions, and telemedicine solutions. Pharmagest Interactive SA's pharmacy management systems include software solutions for inventory management, prescription management, and billing. The company also provides e-learning courses and training for pharmacies. Its healthcare management solutions focus on patient data management, with features such as patient records, appointment scheduling, and prescription management. These solutions are used by healthcare providers to optimize patient data management and improve patient care. Pharmagest Interactive SA also offers telemedicine solutions, including remote visit applications, online consultations, and teleconsultations. These solutions are particularly useful for patients in rural areas or with limited mobility. The company's products and services include Crossway, a pharmacy management software; LGPI, a patient management software for hospitals and healthcare providers; Noviatek, a digital prescription management system; and Monolog, a cloud-based platform for telemedicine services. In summary, Pharmagest Interactive SA provides a variety of digital solutions for pharmacies and healthcare providers, focusing on optimizing patient data management, inventory management, and billing. The company is also a pioneer in telemedicine solutions. Equasens is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Equasens stock

EV/FCF (Enterprise Value to Free Cash Flow) of Equasens is 10.95 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Equasens changed from 15.52 to 10.95, representing a -29.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Equasens since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Equasens with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Equasens

All Key Metrics — Equasens